get a FREE report that covers upcoming FMS drug of JAZZ, a small cap biotech company
By amritadas - Posted on June 11th, 2009
Tagged:
We all know that JAZZ is moving up due to the upcoming data of JZP-6 for the treatment of FMS.But how much is the stock worth? What is the estimated Peak Sales of the drug? Who are its competitors and how does the drug fare compared to these competitors? What exactly is FMS? What is the market size for this disease? To find out about all this, you can get a FREE report that covers this upcoming event at: http://www.newbiomedicine.com
I went through the report that you mentioned….I must say that I am impressed….not only did I get a clear picture regarding FMS, but I have also become very aware of the stock worth. I think it is worth investing. Thank you… Please keep me posted for more such recommendations. All in all…. a great analytical effort by the NEW BIOMEDICINE team. Read the JAZZ report….. I must say that I am very impressed by the analysis.. It was not just detailed but was also extremely informative and EASY to UNDERSTAND. Pls keep up the good work. Thank you